Conference Call & Webcast Details | ||
Date/Time: Participant Dial-In: | 877-407-5795 / 201-689-8722 |
The webcast link will be accessible under “News/Events” on the Investors & Media page of the Company's website at www.bioxceltherapeutics.com.
Replay* | ||
Replay Dial-In: Access ID: | 877-660-6853 / 201-612-7415 13745734 |
*Available through
About
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical fact should be considered forward-looking statements, including, without limitation, the date and time of the release of Company’s first quarter 2024 financial results and related conference call. When used herein, words including “anticipate,” “believe,” “can,” “continue,” “could,” “designed,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon the Company’s current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. The Company may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation, the important factors discussed under the caption “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended
Contact Information
Corporate
1.203.494.7062
ekopp@bioxceltherapeutics.com
Investor Relations
1.475.355.8462
bdoyle@bioxceltherapeutics.com
Media
1.858-717-2310
David.schull@russopartnersllc.com
1.646-942-5630
Scott.stachowiak@russopartnersllc.com
Source:
BT BIOXCEL THERAPEUTICS is a registered trademark of
All other trademarks are the properties of their respective owners.
Copyright © 2024, BioXcel Therapeutics, Inc. All rights reserved.
Source:
2024 GlobeNewswire, Inc., source